Background: Alterations in the insulin-like growth factor (IGF) system have been reported for different tumours. They are of particular interest in the search for new prognostic and therapeutic approaches in cancer. In childhood acute lymphoblastic leukaemia (ALL) the amount of “tumour mass ” at diagnosis can exceed 1 kg. To understand the endocrine, paracrine, and autocrine potential of the malignant transformed progenitor cells, the ability of these cells to express components of the IGF system needs to be investigated. Aim: To characterise the expression pattern of genes of the IGF system in malignant lymphoblasts of children suffering from ALL. Methods: Reverse transcription polymerase chain reaction of Ficoll separated mononuclear cell...
Pre-B acute lymphoblastic leukemia (ALL) de-velops through malignant transformation of pre-cursor B ...
Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia ...
Development of relapse remains a problem for further improvements in the survival of pedi-atric AML ...
IGF1R is emerging as an important gene in the pathogenesis of many solid and haematolo-gical cancers...
Infantile hemangioma (IH) is the most common tumor of the pediatric age group, affecting up to 4 % o...
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with ...
Contains fulltext : 52698.pdf (publisher's version ) (Closed access)Gross cytogene...
PURPOSE: In childhood acute lymphoblastic leukemia (ALL), approximately 25% of patients suffer from ...
Contains fulltext : 155117.pdf (publisher's version ) (Open Access)BACKGROUND: IKZ...
PURPOSE: To determine the prevalence and prognostic association of immunoglobulin heavy chain (IGH@)...
The oncofetal protein insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) belongs to a fam...
Contains fulltext : 80478.pdf (publisher's version ) (Closed access)Lymphoblastic ...
YBRIDOMA TECHNOLOGY, developed in the H mid-1 970s by Kohler and Milstein, ’ made it possible to pro...
The oncofetal protein insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) belongs to a fam...
childrenscolorado.org The t(9;22)(q34;q11) or Philadelphia chromosome creates a BCR–ABL1 fusion gene...
Pre-B acute lymphoblastic leukemia (ALL) de-velops through malignant transformation of pre-cursor B ...
Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia ...
Development of relapse remains a problem for further improvements in the survival of pedi-atric AML ...
IGF1R is emerging as an important gene in the pathogenesis of many solid and haematolo-gical cancers...
Infantile hemangioma (IH) is the most common tumor of the pediatric age group, affecting up to 4 % o...
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with ...
Contains fulltext : 52698.pdf (publisher's version ) (Closed access)Gross cytogene...
PURPOSE: In childhood acute lymphoblastic leukemia (ALL), approximately 25% of patients suffer from ...
Contains fulltext : 155117.pdf (publisher's version ) (Open Access)BACKGROUND: IKZ...
PURPOSE: To determine the prevalence and prognostic association of immunoglobulin heavy chain (IGH@)...
The oncofetal protein insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) belongs to a fam...
Contains fulltext : 80478.pdf (publisher's version ) (Closed access)Lymphoblastic ...
YBRIDOMA TECHNOLOGY, developed in the H mid-1 970s by Kohler and Milstein, ’ made it possible to pro...
The oncofetal protein insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) belongs to a fam...
childrenscolorado.org The t(9;22)(q34;q11) or Philadelphia chromosome creates a BCR–ABL1 fusion gene...
Pre-B acute lymphoblastic leukemia (ALL) de-velops through malignant transformation of pre-cursor B ...
Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia ...
Development of relapse remains a problem for further improvements in the survival of pedi-atric AML ...